This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-ATORVASTATIN

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-ATORVASTATIN in Canada?

Yes. APO-ATORVASTATIN 20MG has an active shortage reported to Health Canada (last updated April 24, 2026).

Why is APO-ATORVASTATIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-ATORVASTATIN be available again?

The estimated resolution date (May 22, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength20MG

Last updated2019-02-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DOM-ATORVASTATIN

DOMINION PHARMACAL

20MG · DIN 02399490

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MYLAN-ATORVASTATIN

MYLAN PHARMACEUTICALS ULC

20MG · DIN 02392941

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ATORVASTATIN

APOTEX INC

20MG · DIN 02396432

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

LIPITOR

BGP PHARMA ULC

10MG · DIN 02230711

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NTP-ATORVASTATIN

TEVA CANADA LIMITED

10MG · DIN 02384787

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

BIO-ATORVASTATIN

BIOMED PHARMA

10MG · DIN 02481189

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02295288

Strength

20MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ATORVASTATIN

Tier

Unrated

Last Updated

2019-02-13

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-ATORVASTATIN has 3 shortage/discontinuation reports on file — this is one of them.

2026-06-26

Resolved

Disruption of the manufacture of the drug.

2026-04-24

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244